UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2024
Commission File No. 001-35193
Grifols, S.A.
(Translation of registrant’s name into English)
Avinguda de la Generalitat, 152-158
Parc de Negocis Can Sant Joan
Sant Cugat del Valles 08174
Barcelona, Spain
(Address of registrant’s principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Grifols, S.A.
TABLE OF CONTENTS
| Item | Sequential Page Number | ||
| 1. | Inside Information Note, dated November 19, 2024 | 3 | |
|
Grifols, S.A. |
| Avinguda de la Generalitat 152-158 | |
| 08174 Sant Cugat del Vallès | |
| Barcelona - ESPAÑA | |
| Tel. [34] 935 710 500 | |
| Fax [34] 935 710 267 | |
| www.grifols.com |
Pursuant to the provisions of article 226 of the Consolidated Text of the Securities Market Act, approved by the Legislative Royal Decree 4/2015, of 23 October, Grifols, S.A. ("Grifols") hereby informs about the following
INSIDE INFORMATION
In relation to the inside information note sent today to the CNMV by Brookfield Capital Partners (UK) Limited, Grifols announces that its Board of Directors will hold an extraordinary meeting this afternoon to analyse the information received. Subsequently, it will issue an opinion regarding Brookfield's communication. The directors who are in conflict of interest will not participate in the issuance of such opinion.
Grifols also announces that the Transaction Committee of the Board of Directors has duly considered Brookfield’s non-binding indicative valuation of €6.45Bn for the entire outstanding share capital of the Company (the aggregate of Class A and B shares), implying an indicative price of €10.50 per share for Class A shares, and has concluded that a potential offer at this valuation level significantly undervalues the Company’s fundamental prospects and its long-term potential. Accordingly, the Transaction Committee would not be in a position to recommend to the Board of Directors to support an offer at this valuation for the Company nor to recommend to the shareholders of the Company the acceptance of a potential offer at the indicated price. The Transaction Committee communicated this fact to Brookfield and has requested the call for the extraordinary meeting referred to above.
In Barcelona, on 19 November 2024.
Thomas Glanzmann
Chairman of the Board of Directors
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
| Grifols, S.A. | |||
| By: | /s/ David I. Bell | ||
| Name: | David I. Bell | ||
| Title: | Authorized Signatory | ||
Date: November 19, 2024